Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2025 Feb 1;179(2):223.
doi: 10.1001/jamapediatrics.2024.6442.

Errors in Table, Figure Title, Byline, and Author Affiliations

No authors listed
Published Erratum

Errors in Table, Figure Title, Byline, and Author Affiliations

No authors listed. JAMA Pediatr. .
No abstract available

PubMed Disclaimer

Erratum for

  • Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024.
    Moline HL, Toepfer AP, Tannis A, Weinberg GA, Staat MA, Halasa NB, Boom JA, Klein EJ, Williams JV, Schuster JE, Goldstein L, McKeever ER, Kalman C, Paden C, Atherton L, Aggarwal M, Roychoudhury P, Piedra PA, Sahni LC, Stewart LS, Selvarangan R, Michaels MG, Schlaudecker EP, Szilagyi PG, Englund JA, Clopper BR, Thornburg NJ, Derado G, McMorrow ML, Dawood FS; New Vaccine Surveillance Network Collaborators. Moline HL, et al. JAMA Pediatr. 2025 Feb 1;179(2):179-187. doi: 10.1001/jamapediatrics.2024.5572. JAMA Pediatr. 2025. PMID: 39652359

Similar articles

See all similar articles

References

    1. Moline HL, Toepfer AP, Tannis A, et al. ; New Vaccine Surveillance Network Collaborators . Respiratory syncytial virus disease burden and nirsevimab effectiveness in young children from 2023-2024. JAMA Pediatr. Published online December 9, 2024. doi:10.1001/jamapediatrics.2024.5572 - DOI - PMC - PubMed

Publication types